You are here: Industry Insights > coronavirus

News List

Immunoprotein impairs Sars-Cov-2 worldpharmanews
July 30, 2020
A protein produced by the human immune system can strongly inhibit corona viruses, including Sars-Cov-2, the pathogen causing Covid-19.
In Vitro Testing Confirms Antiviral Activity of WP1122 in Coronavirus americanpharmaceuticalreview
July 28, 2020
Moleculin Biotech announced a second round of independent laboratory testing has confirmed the antiviral activity of WP1122 against coronavirus.
Gov unveils plans to boost UK's vaccines manufacturing capabilities pharmatimes
July 27, 2020
The government is streaming an additional £100 million into ensuring that any COVID-19 vaccine making it to the finish line can be produced at scale in the UK.
People at high risk of diabetes fast-tracked into prevention programme pharmatimes
July 27, 2020
People at high risk of developing type II diabetes will be fast-tracked into the Healthier You NHS Diabetes Prevention programme, on the back of research indicating that people with the condition are at significantly higher risk of dying with COVID-19.
Why is a romance burgeoning between pharma and telehealth? expresspharma
July 27, 2020
An analysis of how these growing alliances can enable the pharma sector to seek more effective ways to reach out and communicate with prescribers and KoLs.
Researchers identify 21 existing drugs that block coronavirus in lab studies expresspharma
July 27, 2020
The study said that four of these compounds could work in combination with remdesivir, a current standard-of-care treatment for COVID-19.
Scientists decode how coronavirus molecules camouflage in host cell expresspharma
July 27, 2020
According to the researchers, this development may pave the way for the design of new drugs against the novel coronavirus SARS-CoV-2, and other emerging coronavirus infections.
China’s Sinopharm says coronavirus vaccine could be ready by year-end – state media expresspharma
July 24, 2020
Sinopharm Chairman Liu Jingzhen told state broadcaster CCTV the company expects to finish late-stage human testing within about three months.
Merck, contract research firm IRBM partner on coronavirus therapies pharmaceutical-technology
July 22, 2020
Merck (MSD) has collaborated with contract research services company IRBM for the identification and development of new peptide therapeutics that can target various strains of coronavirus, including SARS-CoV-2.
Six people tests coronavirus positive in Maha FDA expresspharma
July 22, 2020
Six staff of the Maharashtra Food and Drug Administration’s (FDA) have tested coronavirus positive.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page